CD79A and myeloid sarcoma: Importantly, we also observed that a combination of IgG, IgM, and IgA responses to HHV-6 and EBV-dUTPase significantly predicted the severity of disabilities due to MS (as measured by the EDSS) and disease progression (as assessed with the MSSS scale).